Effects of Dronabinol in Opioid Maintained Patients (NCT04025359)
The Effects of Dronabinol in Opioid-Related Outcomes
🩺 Plain-English Summary (8th-Grade Level)
Twenty male and female (ages 18-70) participants with OUD currently receiving methadone or buprenorphine will be enrolled. Prior to their daily methadone or buprenorphine dose and thus at trough plasma levels of opioid, participants will receive dronabinol (2.5 mg, 5mg) or placebo. Subsequently, all participants will undergo laboratory testing of opioid-related outcomes. Pain sensitivity will be measured using a technique called the (QST) quantitative sensory testing, which involves the administering heat or cold stimulation. A Short-Form McGill Pain Questionnaire (SF-MPQ) and a pain Visual Analog Scale (VAS). Attentional bias will be measured using a visual probe task. Negative affect will be measured using the Positive and Negative Affect Schedule (PANAS). Cognitive performance will be measured by a comprehensive cognitive battery. The order of study medication administration will be counterbalanced order to minimize carryover effects. On the initial screening day and at the end of medication treatment, blood will be drawn to determine serum cytokine levels. One week after the last study medication dose, a follow-up session will be conducted during which participants will undergo urine toxicology testing and a safety evaluation before final discharge from the study.
Who can join: Review the eligibility criteria below.
Location: VA Connecticut Healthcare System — West Haven, Connecticut
Age range: 18 Years to 70 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- VA Connecticut Healthcare System — West Haven, Connecticut
📞 Contact the Study Coordinator
Phone: (203) 932-5711
Email: joao.deaquino@va.gov
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Pain
- AnalgeSiC and appEtite-stimulating Effects of caNnabigerol and THC (ASCENT) — Los Angeles, California
- Neuromodulation as a Treatment for Chemotherapy-Induced Peripheral Neuropathy — Houston, Texas
- App Delivered Brief Mindfulness Intervention for Surgical Patients — Salt Lake City, Utah
- Intravenous (IV) Hydrocortisone for TKA (Total Knee Arthroplasty) — New York, New York
- Neural Mechanisms of Immersive Virtual Reality in Chronic Pain — Baltimore, Maryland
- Effects of Neurofeedback on Neural Function, Neuromodulation, and Chemotherapy-Induced Neuropathic Pain — Houston, Texas
Explore by condition: All Pain clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.